Protection against HIV Acquisition in the RV144 Trial-Reference-Cited by-同舟云学术

Protection against HIV Acquisition in the RV144 Trial

Published:2017-09-15 Issue:18 Volume:91 Page:
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:J Virol

Author:

Desrosiers Ronald C.¹^ORCID

Affiliation:

1. University of Miami Miller School of Medicine, Miami, Florida, USA

Abstract

ABSTRACT Differences of opinion regarding whether there may, or may not, have been protective efficacy in the RV144 vaccine trial have important societal implications.

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/JVI.00905-17

Reference10 articles.

1. Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

2. Immune correlates of vaccine protection against HIV-1 acquisition

3. Fauci AS . 2017. Towards an HIV vaccine: a scientific journey. https://www.youtube.com/watch?v=8iHK3B-g7GI. Accessed June 2017.

4. Statistical Interpretation of the RV144 HIV Vaccine Efficacy Trial in Thailand: A Case Study for Statistical Issues in Efficacy Trials

5. Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potent antibody-dependent cellular cytotoxicity of a V2-specific antibody is not sufficient for protection of macaques against SIV challenge;PLOS Pathogens;2024-01-22

2. Potent antibody-dependent cellular cytotoxicity of a V2-specific antibody is not sufficient for protection of macaques against SIV challenge;2023-11-15

3. The Failure of AIDS Vaccine Efficacy Trials: Where to Go from Here;Journal of Virology;2023-03-30

4. Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses;Journal of Virology;2022-04-27

5. Testing a global null hypothesis using ensemble machine learning methods;Statistics in Medicine;2022-03-07